Artificial Intelligence in Endoscopic Ultrasound

Part of paid clinical trials in Orlando, Florida.

Sponsor
Orlando Health, Inc.
Study ID
NCT06564571
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • Patients undergoing endoscopic ultrasound procedures — DEVICE
    Patients will undergo endoscopic ultrasound procedures as planned. Abnormalities in the pancreas identified by the endoscopist during the endoscopic ultrasound examination will be correlated against those detected by the AI platform.

Study Details

The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.

Key Dates

Start date
Jan 19, 2024
Status verified
Aug 2024
Primary completion
Dec 31, 2026
Completion
Dec 31, 2027

Study Design

Enrollment
310 participants (estimated)

Arms

  • Arm: Patients undergoing endoscopic ultrasound procedures
    Patients will undergo endoscopic ultrasound procedures as planned. Abnormalities in the pancreas identified by the endoscopist during the endoscopic ultrasound examination will be correlated against those detected by the AI platform.

Primary Outcome Measure

Rate of detection pancreatic abnormalities by AI [ Time Frame: 1 day ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Orlando HealthOrlandoFlorida32806
Shyam Varadarajulu, MD
[email protected]
321-841-2431
Barbara Broome
[email protected]
321-841-4356

Find similar trials in Orlando, FL

By condition
Pancreatic cancer
By specialty
OncologyGI oncology
By research site
Orlando Health· Orlando, FL

Related Studies